Pharmaceutical group

Hengrui

11 medicines3 countries

A group of 5 companies with 11 medicines in 3 countries.

Its medicines

Group structure

5 companies in 2 countries

China3

Singapore1

Hengrui Sg Pte. Ltd.Authorisation holder · 3 medicines

Headquarters not stated1

Hengrui PharmaAuthorisation holder · 3 medicines · listed in United States

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine of every company in the group, current ones first.

11 medicines

Medicine	Substance	Country	Status	Authorised
BUPIVACAINE LIPOSOME133mg/10ml (13.3mg/ml) \| 266mg/20ml (13.3mg/ml) · Injectable, liposomal	Bupivacaine	United States	Not marketed	2024
DESFLURANE100% · Liquid	Desflurane	United States	Marketed	2018
GADOBUTROL1.20944gm/2ml (604.72mg/ml) \| 18.1416gm/30ml (604.72mg/ml) \| 39.3068gm/65ml (604.72mg/ml) \| 4.5354gm/7.5ml (604.72mg/ml) \| 6.0472gm/10ml (604.72mg/ml) \| 9.0708gm/15ml (604.72mg/ml) · Solution	Gadobutrol	United States	Marketed	2022
HEAREM SEVOFLURANE INHALATION ANAESTHETIC LIQUID 100%100% · Inhalant	Sevoflurane	Singapore	Authorised	2025
HENGRUI IODIXANOL SOLUTION FOR INJECTION 270 MG I/ML270 mg/mL · Injection, solution	Iodixanol	Singapore	Authorised	2026
HENGRUI IODIXANOL SOLUTION FOR INJECTION 320 MG I/ML320 mg/mL · Injection, solution	Iodixanol	Singapore	Authorised	2026
IODIXANOL55% \| 65.2% · Injectable	Iodixanol	United States	Marketed	2022
GEBTIN	Gemcitabine	Saudi Arabia	Authorised
Tadoxel	Docetaxel	Saudi Arabia	Authorised
Tadoxel 80 mg/4 ml	Docetaxel	Saudi Arabia	Authorised
Vaprena	Tolvaptan	Saudi Arabia	Authorised

Sources and licences

Country	Medicines	Current	Companies
Saudi Arabia	4	4	Companies All medicines
United States	4	4	Companies All medicines
Singapore	3	3	Companies All medicines

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.

U.S. Food and Drug Administration (Drugs@FDA, openFDA)

Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.

Licence: Public domain (U.S. Government work)

Anvisa, Brazil

Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.

Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions

INVIMA

Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.

Licence: CC BY-SA 4.0

Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA)

Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.

Licence: CC BY-SA 4.0

National Pharmaceutical Regulatory Agency / Ministry of Health Malaysia

National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.

Licence: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication

Saudi Food and Drug Authority

Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.

Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only

All 8 sources

Accounting and Corporate Regulatory Authority (ACRA), via Data.gov.sg

Contains information from ACRA Information on Corporate Entities, accessed on 8 October 2026 through Data.gov.sg, under Singapore Open Data Licence version 1.0: https://data.gov.sg/open-data-licence. Structured selection and normalisation by Prognia; original UEN, field and retrieval date retained.

Licence: Singapore Open Data Licence

Health Sciences Authority / data.gov.sg

Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence

Licence: Singapore Open Data Licence

Report an error or request removal Corrections from the company itself are welcome.

Hengrui

Group structure

China3

Singapore1

Headquarters not stated1

Medicines

Know your medicines, with the sources.

Hengrui

Group structure

China3

Singapore1

Headquarters not stated1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Work with Prognia

Other big groups

Group structure

🇨🇳China3

🇸🇬Singapore1

Headquarters not stated1

Medicines

Know your medicines, with the sources.

Group structure

🇨🇳China3

🇸🇬Singapore1

Headquarters not stated1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Work with Prognia

China3

Singapore1

China3

Singapore1